Skip to main content
. Author manuscript; available in PMC: 2015 May 20.
Published in final edited form as: Oncogene. 2013 Nov 18;33(47):5457–5466. doi: 10.1038/onc.2013.486

Fig. 2. K-RasG12V transformation affects KIF2C expression more than loss of p53.

Fig. 2

(A) KIF2C and KIF2A were immunoblotted in HBEC3KTRL53 following depletion of K-Ras with siRNA compared to a non-targeting control siRNA. (B) KIF2C was immunoblotted in HBEC30KT following depletion of p53 with siRNA compared to non-targeting control siRNA. (C) KIF2C was immunoblotted in lysates of HBEC3KTRL53 or (D) KIF2A was immunoblotted in HBEC3KT and H358 in each case following re-expression of p53.